- Home
- NRIX vs FLO Comparison
NRIX vs FLO Comparison
Compare NRIX & FLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | FLO |
|---|---|---|
| Founded | 2009 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NRIX | FLO |
|---|---|---|
| Price | $17.75 | $7.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $30.50 | $11.20 |
| AVG Volume (30 Days) | 874.4K | ★ 8.4M |
| Earning Date | 04-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 11.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $76,987,000.00 | ★ $5,256,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.05 | $0.65 |
| P/E Ratio | ★ N/A | $38.33 |
| Revenue Growth | ★ 99.31 | 3.00 |
| 52 Week Low | $8.20 | $6.80 |
| 52 Week High | $22.50 | $16.96 |
Technical Indicators
Market Signals| Indicator | NRIX | FLO |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 43.52 |
| Support Level | $17.21 | $6.80 |
| Resistance Level | $19.98 | $8.94 |
| Average True Range (ATR) | 0.80 | 0.39 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 88.45 | 46.61 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About FLO Flowers Foods Inc.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.